Oppenheimer & Co. Inc. Increases Position in Amdocs Limited (NASDAQ:DOX)

Oppenheimer & Co. Inc. lifted its holdings in Amdocs Limited (NASDAQ:DOX) by 5.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 43,808 shares of the technology company’s stock after buying an additional 2,447 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Amdocs were worth $3,730,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Pzena Investment Management LLC boosted its position in Amdocs by 12.3% in the 3rd quarter. Pzena Investment Management LLC now owns 6,363,739 shares of the technology company’s stock valued at $556,700,000 after buying an additional 696,136 shares during the period. Hotchkis & Wiley Capital Management LLC raised its stake in shares of Amdocs by 123.2% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 759,136 shares of the technology company’s stock valued at $66,409,000 after acquiring an additional 419,045 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Amdocs by 1,207.3% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 271,701 shares of the technology company’s stock valued at $23,768,000 after purchasing an additional 250,918 shares during the period. Geode Capital Management LLC grew its stake in Amdocs by 10.8% in the third quarter. Geode Capital Management LLC now owns 1,633,733 shares of the technology company’s stock worth $143,498,000 after purchasing an additional 158,843 shares in the last quarter. Finally, Nordea Investment Management AB increased its holdings in Amdocs by 8.3% during the 4th quarter. Nordea Investment Management AB now owns 1,656,055 shares of the technology company’s stock worth $141,112,000 after purchasing an additional 127,426 shares during the period. 92.02% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have weighed in on DOX shares. StockNews.com cut Amdocs from a “strong-buy” rating to a “buy” rating in a report on Friday. Oppenheimer upped their price target on shares of Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. Finally, Barclays cut their price objective on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a report on Thursday, November 14th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $101.20.

Amdocs Stock Performance

DOX stock opened at $87.25 on Friday. Amdocs Limited has a one year low of $74.41 and a one year high of $94.04. The firm has a market cap of $9.85 billion, a price-to-earnings ratio of 20.24, a PEG ratio of 1.47 and a beta of 0.71. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.20 and a current ratio of 1.16. The firm has a 50-day simple moving average of $86.22 and a two-hundred day simple moving average of $86.81.

Amdocs (NASDAQ:DOX) last posted its quarterly earnings data on Tuesday, February 4th. The technology company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. On average, equities analysts forecast that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Monday, March 31st will be given a $0.527 dividend. This is a boost from Amdocs’s previous quarterly dividend of $0.48. The ex-dividend date is Monday, March 31st. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.42%. Amdocs’s dividend payout ratio (DPR) is presently 48.72%.

Amdocs Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.